Characterization of the otorrinolaringological manifestations in patients with HIV/AIDS infection in the city of Cartagena
Article Sidebar
Main Article Content
Abstract
Introduction: In Colombia, the incidence of the disease has been increasing and Cartagena has the highest numbers of the country. Otorhinolaryngological manifestations
in people with HIV/AIDS are estimated between 20%-80% generating a great impact on quality of life. Objective: To determine the epidemiological characteristics and otorhinolaryngological manifestations in a group of people with HIV / AIDS
in the city of Cartagena. Methodology: Observational, descriptive, cross-sectional and prospective design. Information was collected from patients with HIV from the city of Cartagena who attended 2 medical centers, a questionnaire was applied to obtain epidemiological data, otorhinolaryngological signs and symptoms, as well as a complete otorhinolaryngological physical examination. Results: 150 patients were included in the study, with a mean age of 31 years, 59.3% male and 40.7% female.
The most frequent non-otorhinolaryngological pathological antecedent was syphilis coinfection in 10% and otorhinolaryngological, sinusitis and oral candidiasis each with 3.3%. 73% of the patients at the time of the evaluation manifested otorhinolaryngological alteration, the otological ones being the most frequent with 39.9% of the patients. Furthermore, a significant relationship was observed between CD4 counts and findings such as laryngeal dysphonia (p = 0.045). Conclusions: The otological
manifestations were the most frequent in our environment and a relationship was found between the CD4 count and the laryngeal manifestations of the disease.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.
Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.
eISSN: 2539-0856
ISSN: 0120-8411
References
Teva I, Bermúdez MP, Ramiro MT, Buela-Casal G. Current epidemiological situation of HIV/AIDS in Latin America:
analysis of differences among countries. Rev Med Chil. 2012;140(1):50-8.
Instituto Nacional de Salud. Comportamiento del VIH/SIDA Colombia, semana epidemiológica 47 (18 al 24 de noviembre
de 2018). Boletín epidemiológico semanal 2018.
El Howati A, Tappuni A. Systematic review of the changing pattern of the oral manifestations of HIV. J Investig Clin Dent.
;9(4):e12351.
Patton LL. Progress in understanding oral health and HIV/ AIDS. Oral Dis. 2014;20(3):223-5.
Leao JC, Ribeiro CMB, Carvalho AAT, Frezzini C, Porter S. Oral complications of HIV disease. Clinics. 2009;64(5):459-70.
Tshifularo M, Govender L, Monama G. Otolaryngological and head and neck manifestations in HIV-infected patients seen at Steve Biko Academic Hospital in Pretoria, South Africa. South African Med J. 2013;103(7):464-6.
Kirti YK, Yashveer JK, Poorey VK. Changing Trends of HIV/AIDS in Otorhinolaryngology with CD4+ Count Correlation.
Indian J Otolaryngol Head Neck Surg. 2014;67(1):12-5.
Iacovou E, Vlastarakos P V., Papacharalampous G, Kampessis G, Nikolopoulos TP. Diagnosis and treatment of HIV-associate dmanifestations in otolaryngology. Infect Dis Rep. 2012;4(1):9.
Prasad HK, Bhojwani KM, Shenoy V PS. HIV manifestations in otolaryngology. Am J Otolaryngol. 2006;27(1–3):179-94.
Lalwani A SC. Otologic and neurotologic manifestations of acquired-immunodeficiency-syndrome. Otolaryngol Clin
North Am. 1992;25(6):1183-97.
Yamini Y, Mandelia C, Sreedharan S. Otorhinolaryngological manifestations among HIV positive children in coastal
Karnataka. J Clin Diagnostic Res. 2015;9(3).
Fasunla AJ, Daniel A, Nwankwo U, Kuti KM, Nwaorgu OG, Akinyinka OO. Evaluation of Olfactory and Gustatory Function
of HIV Infected Women. AIDS Res Treat. 2016;2016:2045383.
Gaurav S, Keerthilatha PM, Archna N. Prevalence of oral manifestations and their association with CD4/CD8 ratio and
HIV viral load in South India. Int J Dent. 2011;2011:964278.
Lourenço AG, Motta ACF, Figueiredo LTM d., Machado AA, Komesu MC. Oral lesions associated with HIV infection before and during the antiretroviral therapy era in Ribeirão Preto, Brazil. J Oral Sci. 2011;53(3):37985.
Neil Hamilton Wood AM. HIV-Associated Oral Lesions in HIV-Seropositive Patients at an HIVTreatment Clinic in South
Africa. J AIDS Clin Res. 2015;6(2).
Mary EO, Abiola OA, Titilola G, Mojirayo OO, Sulaimon AA. Prevalence of HIV related oral lesions in people living
with HIV and on combined antiretroviral therapy: A Nigerian experience. Pan Afr Med J. 2018;31:1-10.
Bakhshaee M, Sarvghad MR, Khazaeni K, Movahed R, Hoseinpour AM. HIV: An epidemiologic study on head and
neck involvement in 50 patients. Iran J Otorhinolaryngol. 2014;26(75):97-103.
Dompreh A. Lesions de l’ oreille, du nez et de la gorge chez les patients infectes par le VIH/SIDA au centre ospitalier
universitaire d’ komfo anoky subvention de soutien: aucune. J West African Coll Surg. 2012;2(2):1-16.
Jafari S, Razmpa E, Saeedinejad Z, Sadrhosseini M, Paydary K, Saedi B, et al. Otolaryngological manifestations in HIV
infected patients, Tehran, Iran. J AIDS Clin Res. 2012;3(6):3-6.
Jiménez Malagón MC, Harris Ricardo J, Palomino Rossi W, Díaz Caballero AJ, del Río EP. Manifestaciones orales en
pacientes VIH/SIDA asociadas a tratamiento antirretroviral y el estado inmunológico en dos fundaciones de la ciudad de
Cartagena. Av Odontoestomatol. 2012;28(4):181-9.
Sulyman AB, Kazeem SA, Abdulrahman A, David D, Kayode AS, Oluwayemisi O, et al. Otolaryngologic manifestations
among HIV/AIDS patients in a Nigerian tertiary health institution: an update. Arq Int Otorrinolaringol. 2010;14(4):398-
Torre P, Hoffman HJ, Springer G, Cox C, Young M, Margolick JB, et al. Cochlear function among HIV-seropositive and HIVseronegative men and women. Ear Hear. 2014;35(1):56-62.
Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N. Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients. Ann Acad Med Singapore. 2004;33(4 Suppl.):37-42.
Tappuni AR, Fleming GJP. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected
patients: A UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(6):623-8.
Cortes J, Moreno A, Alvarez C, Tamara J. Experience with lopinavir/ritonavir for patients with HIV infection at an
university hospital in Bogotá, Colom. Infectio. 2006;10(4):220-5.
Bravo IM, Correnti M, Escalona L, Perrone M, Brito A, Tovar V, et al. Prevalencia de lesiones bucales en pacientes
VIH+, relación con contaje de células CD4+ y carga viral en una población venezolana. Med Oral Patol Oral Cir Bucal.
;11(1):25-31.